NCT01432340View on ClinicalTrials.gov

Seasonal Influenza Vaccine Effectiveness Study in Kenya

CompletedOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

March 18, 2014

Study Completion Date

March 18, 2014

Conditions
InfluenzaInfluenza Like IllnessSevere Acute Respiratory Illness
Interventions
BIOLOGICAL

Seasonal influenza vaccine

annual recommended Southern Hemisphere vaccine

Trial Locations (2)

Unknown

KEMRI/CDC- IEIP surveillance-Asembo, Kisumu

KEMRI/CDC IEIP surveillance- Kibera, Nairobi

Sponsors
All Listed Sponsors
collaborator

Kenya Ministry of Health

OTHER_GOV

collaborator

Kenya Medical Research Institute

OTHER

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

Gideon Emukule

FED